R&D Scientist at Thermo Fisher Scientific, Cell Biology ADME/Tox groupBiography
Mark received his Ph.D. from Memorial University (Canada). Under the guidance of Ken R. Kao, in the Terry Fox Cancer Research Laboratory, he investigated mechanisms by which growth factor signaling controls stem cell differentiation in embryonic development. As a Cancer Research Training Award (CRTA) post-doctoral fellow in the laboratory of Terry P. Yamaguchi at the National Cancer Institute, Dr. Kennedy studied the gene regulatory network controlled by Wnt signaling in models of mammalian embryogenesis. He has published many peer-reviewed research articles in leading journals such as PNAS and Development. At Thermo Fisher Scientific, Dr. Kennedy is part of a team that focuses on the development of new in vitro 3D cell culture models. His ongoing work focusses on the utilization of human embryonic stem cells, iPSCs and primary cells, and their application in spheroids, organoids and co-culture systems.